GRF(1-29) raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-10. Anything still debated is marked as such rather than presented as settled.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
In 2005, ten countries accounted for the majority of the world's concentrated uranium oxides: Canada (27.9%), Australia (22.8%), Kazakhstan (10.5%), Russia (8.0%), Namibia (7.5%), Niger (7.4%), Uzbekistan (5.5%), the United States (2.5%), Argentina (2.1%) and Ukraine (1.9%). In 2008, Kazakhstan was forecast to increase production and become the world's largest supplier of uranium by 2009; Kazakhstan has dominated the world's uranium market since 2010. In 2021, its share was 45.1%, followed by Namibia (11.9%), Canada (9.7%), Australia (8.7%), Uzbekistan (7.2%), Niger (4.7%), Russia (5.5%), China (3.9%), India (1.3%), Ukraine (0.9%), and South Africa (0.8%), with a world total production of 48,332 tonnes. Most uranium was produced not by conventional underground mining of ores (29% of production), but by in-situ leaching (66%). In the late 1960s, UN geologists discovered major uranium deposits and other rare mineral reserves in Somalia. The find was the largest of its kind, with industry experts estimating the deposits at over 25% of the world's then known uranium reserves of 800,000 tons. The ultimate available supply is believed to be sufficient for at least the next 85 years, though some studies indicate underinvestment in the late twentieth century may produce supply problems in the 21st century. Uranium deposits seem to be log-normal distributed. There is a 300-fold increase in the amount of uranium recoverable for each tenfold decrease in ore grade. In other words, there is little high grade ore and proportionately much more low grade ore available.
Carboxypeptidase E functions in the production of nearly all neuropeptides and peptide hormones. The enzyme acts as an exopeptidase to activate neuropeptides. It does that by cleaving off basic C-terminal amino acids, producing the active form of the peptide. Products of carboxypeptidase E include insulin, the enkephalins, vasopressin, oxytocin, and most other neuroendocrine peptide hormones and neuropeptides. It has been proposed that membrane-associated carboxypeptidase E acts as a sorting signal for regulated secretory proteins in the trans-Golgi network of the pituitary and in secretory granules; regulated secretory proteins are mostly hormones and neuropeptides. However, this role for carboxypeptidase E remains controversial, and evidence shows that this enzyme is not necessary for the sorting of regulated secretory proteins.
After he teaches them to bark on all fours to fend off cats, the family holds a memorial service for the brother. Christina again barters for oral sex from the elder daughter. The daughter rejects her offer of hair gel and demands the Hollywood VHS tapes in her bag. She watches the films (Rocky IV and Jaws) in secret and afterwards recreates scenes and quotes their dialogue. When the father discovers the tapes, he beats her with one of them, then goes to Christina's flat and hits her with her VCR, cursing her future children to be corrupted by "bad influences". The parents decide that, with Christina no longer available, they will have the son choose one of his sisters as a new sexual partner. After fondling both sisters with his eyes closed, he chooses the elder. She is uncomfortable during their sex and afterwards threatens her brother in the style of Hollywood film dialogues. During a performance for the parents' wedding anniversary, the younger daughter stops to rest, but the elder continues and dances the choreography from Flashdance, disturbing her parents. That night, she knocks out one of her dogteeth with a dumbbell and hides in the boot of her father's car. The father discovers her tooth fragments and searches for her fruitlessly. He drives to work the next day; the car sits outside the factory, unattended.
One study estimated that 10 square meters of oyster reef could enhance an ecosystem's biomass by 2.57 kg Herbivore shellfish will also be preyed on. This moves energy directly from primary producers to higher trophic levels potentially skipping out on multiple energetically costly trophic jumps which would increase biomass in the ecosystem. Seaweed farming is a carbon negative crop, with a high potential for climate change mitigation. The IPCC Special Report on the Ocean and Cryosphere in a Changing Climate recommends "further research attention" as a mitigation tactic. Regenerative ocean farming is a polyculture farming system that grows a mix of seaweeds and shellfish while sequestering carbon, decreasing nitrogen in the water and increasing oxygen, helping to regenerate and restore local habitat like reef ecosystems.
Hyperacute rejection occurs when, before the transplantation, the recipient has preformed anti-HLA antibodies, perhaps by previous blood transfusions (donor tissue that includes lymphocytes expressing HLA molecules), by anti-HLA generated during pregnancy (directed at the father's HLA displayed by the fetus), or by previous transplantation; Acute cellular rejection occurs when the recipient's T lymphocytes are activated by the donor tissue, causing damage via mechanisms such as direct cytotoxicity from CD8 cells. Acute humoral rejection and chronic disfunction occurs when the recipient's anti-HLA antibodies form directed at HLA molecules present on endothelial cells of the transplanted tissue. In all of the above situations, immunity is directed at the transplanted organ, sustaining lesions. A cross-reaction test between potential donor cells and recipient serum seeks to detect presence of preformed anti-HLA antibodies in the potential recipient that recognize donor HLA molecules, so as to prevent hyperacute rejection. In normal circumstances, compatibility between HLA-A, -B, and -DR molecules is assessed. The higher the number of incompatibilities, the lower the five-year survival rate. Global databases of donor information enhance the search for compatible donors. The involvement in allogeneic transplant rejection appears to be an ancient feature of MHC molecules, because also in fish associations between transplant rejections and (mis-)matching of MHC class I and MHC class II were observed.
Sources: en.wikipedia.org
Portugal's manufacturing industry accounted for 21.2% of the country's total GDP as of 2024, down from an annual average of 26% over the period between 1953 and 1973. The lower contribution of manufacturing to Portugal's economy has led to lower real GDP growth rates between 1974 and 2019 than during the period between 1950 and 1973. As of 2025, Portugal's automobile industry produced the biggest share of the country's exports. The automobile industry accounts for 20.2% of the country manufacturing exports and 82.8% of the total value of its exports employing 43.247 workers in 2020. Portugal's service sector accounted for 76.5% of the country's total economic output as of 2024. Tourism, retail, and telecommunication are all major industries. Tourism represented 11.8% of the Portugal's total GDP as of 2025. Portugal attracted nearly 30 million international tourists in 2025, ranking 15th in the world in that year for inbound tourism.
The taxonomy of the Liliaceae has a very complex history. The family was first described in the eighteenth century, and over time many other genera were added until it became one of the largest of the monocotyledon families, and also extremely diverse. Modern taxonomic systems, such as the APG which is based on phylogenetic principles using molecular biology, have redistributed many of these genera resulting in the relatively small family that is currently recognised. Consequently, there are many different accounts of the Liliaceae in the literature and older uses of the term occur commonly. To distinguish between them, the Latin terms sensu lato and sensu stricto are frequently used (together with their abbreviations, s.l. and s.s.) to denote the broader or stricter sense of the circumscription respectively, e.g. Liliaceae s.s..
Signal transducer and activator of transcription 5A is a protein that in humans is encoded by the STAT5A gene. STAT5A orthologs have been identified in several placentals for which complete genome data are available.
1993/1250) Aviation Security (Jersey) Order 1993 (S.I. 1993/1251) Financial Provisions (Northern Ireland) Order 1993 (S.I. 1993/1252) Serbia and Montenegro (United Nations Sanctions) (Channel Islands) Order 1993 (S.I. 1993/1253) Serbia and Montenegro (United Nations Sanctions) (Isle of Man) Order 1993 (S.I. 1993/1254) Maximum Number of Judges (No. 2) Order 1993 (S.I. 1993/1255) Arbitration (Foreign Awards) Order 1993 (S.I. 1993/1256) Designs (Convention Countries) Order 1993 (S.I. 1993/1257) Patents and Marks (Convention and Relevant Countries) Order 1993 S.I. 1993/1258) Hackney and Tower Hamlets (London Borough Boundaries) Order 1993 (S.I. 1993/1260) Bromley and Lewisham (London Borough Boundaries) Order 1993 (S.I. 1993/1261) Kensington and Chelsea and Westminster (London Borough Boundaries) Order 1993 (S.I. 1993/1262) Food Premises (Registration) (Welsh Form of Application) Regulations 1993 (S.I. 1993/1270) Greenwich and Lewisham (London Borough Boundaries) Order 1993 (S.I. 1993/1276) Ealing, Hillingdon and Hounslow (London Borough Boundaries) Order 1993 (S.I. 1993/1277) Treatment of Spruce Bark Order 1993 (S.I. 1993/1282) Plant Health (Forestry) (Great Britain) Order 1993 (S.I. 1993/1283) Prohibition of the Keeping or the Release of Live Fish (Pikeperch) (Scotland) Order 1993 (S.I. 1993/1288) A27 Trunk Road (Patching Junction Improvement) Order 1993 (S.I. 1993/1293) A27 Trunk Road (Patching Junction Improvement Slip Roads) Order 1993 (S.I. 1993/1294) A27 Trunk Road (Patching Junction Improvement) (Detrunking) Order 1993 (S.I. 1993/1295)
Sources: en.wikipedia.org
When asked if Trump supported the Arab leaders' plan, a White House spokesman said that the current Arab plan does not address that Gaza is "currently uninhabitable" for Palestinians to live in to due to the amount of debris and unexploded ordnance, adding that "President Trump stands by his vision to rebuild Gaza free from Hamas. We look forward to further talks to bring peace and prosperity to the region." The US special envoy Steve Witkoff said the plan had "compelling features", was a good first step, and they needed additional discussions. The plan was also endorsed by the Organisation of Islamic Cooperation and several European countries. On 12 March, Arab foreign ministers confirmed continuous consultations on Egypt's plan with the US special envoy.
== Biuret test == The biuret test is a chemical test for proteins and polypeptides. It is based on the biuret reagent, a blue solution that turns violet upon contact with proteins, or any substance with peptide bonds. The test and reagent do not actually contain biuret; they are so named because both biuret and proteins have the same response to the test.
The Oxford crew weighed an average of nearly 2 pounds (0.91 kg) more per rower than their opponents. Oxford's Matthew Pinsent was the heaviest rower while Cambridge's Sinclair Gore was the youngest, aged 19. Cambridge's crew featured three returning Blues in Dirk Bangert, David Gillard and James Behrens, while Oxford saw five former Boat Race rowers return. Overall, half of the rowers were non-British (six nationalities representing Oxford, three representing Cambridge) and the same number were postgraduates. The Cambridge boat club president Behrens claimed: "All our boat are at Cambridge on academic merit. They came for a particular course ... and they also row." In contrast, an editorial in The Times claimed: "The performers are no longer ingenuous native undergraduates but supercharged, international, professional rowing machines." Oxford's Bruce Robertson (men's eight) and Pinsent (coxless pair) were both gold medallists at the Barcelona Olympics. A late change in the Oxford cox saw Samantha Benham replace Gordon Buxton to steer the Dark Blues, becoming the eighth female cox in the history of the race. Oxford's Royle noted that Buxton's form had declined in the run-in to the race, while Benham was "handling the pressure a lot better." Cambridge cox, Martin Haycock, suggested that female coxes were not as accomplished as their male counterparts: "We had one cox who was exceptionally good at giving massages but on the whole ... they're not aggressive or tough enough." Oxford also saw a change to their crew in the week preceding the race.
=== Classification === Four commonly accepted criteria for classifying patients with MCTD have been published: the Sharp criteria (1987), the Alarcón-Segovia criteria (1987), the Kasukawa criteria (1987), and the Kahn criteria (1991). The Alarcon-Segovia and Kahn criteria have equivalent sensitivity and specificity, and a comparison of the four diagnostic criteria suggests that the Kasukawa criteria provide the best sensitivity, while both Alarcon-Segovia and Kahn criteria have the maximum specificity.
=== Salvage pathway === Constitutive degradation of sphingolipids and glycosphingolipids takes place in the acidic subcellular compartments, the late endosomes and the lysosomes, with the end goal of producing sphingosine. In the case of glycosphingolipids, exohydrolases acting at acidic pH optima cause the stepwise release of monosaccharide units from the end of the oligosaccharide chains, leaving just the sphingosine portion of the molecule, which may then contribute to the generation of ceramides. Ceramide can be further hydrolyzed by acid ceramidase to form sphingosine and a free fatty acid, both of which are able to leave the lysosome, unlike ceramide. The long-chain sphingoid bases released from the lysosome may then re-enter pathways for synthesis of ceramide and/or sphingosine-1-phosphate. The salvage pathway re-utilizes long-chain sphingoid bases to form ceramide through the action of ceramide synthase. Thus, ceramide synthase family members probably trap free sphingosine released from the lysosome at the surface of the endoplasmic reticulum or in endoplasmic reticulum-associated membranes. The salvage pathway has been estimated to contribute from 50% to 90% of sphingolipid biosynthesis.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.